244 related articles for article (PubMed ID: 25945588)
1. Pasireotide for the Medical Management of Feline Hypersomatotropism.
Scudder CJ; Gostelow R; Forcada Y; Schmid HA; Church D; Niessen SJ
J Vet Intern Med; 2015; 29(4):1074-80. PubMed ID: 25945588
[TBL] [Abstract][Full Text] [Related]
2. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
[TBL] [Abstract][Full Text] [Related]
3. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus.
Reusch CE; Kley S; Casella M; Nelson RW; Mol J; Zapf J
Vet Rec; 2006 Feb; 158(6):195-200. PubMed ID: 16474053
[TBL] [Abstract][Full Text] [Related]
4. Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus.
Scudder CJ; Hazuchova K; Gostelow R; Church DB; Forcada Y; Fowkes RC; Niessen SJ
J Feline Med Surg; 2021 Feb; 23(2):131-137. PubMed ID: 32684121
[TBL] [Abstract][Full Text] [Related]
5. Screening diabetic cats for hypersomatotropism: performance of an enzyme-linked immunosorbent assay for insulin-like growth factor 1.
Rosca M; Forcada Y; Solcan G; Church DB; Niessen SJ
J Feline Med Surg; 2014 Feb; 16(2):82-8. PubMed ID: 23828811
[TBL] [Abstract][Full Text] [Related]
6. Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism.
Miceli DD; García JD; Pompili GA; Rey Amunategui JP; Ferraris S; Pignataro OP; Guitelman M
J Feline Med Surg; 2022 Dec; 24(12):1238-1244. PubMed ID: 35133181
[TBL] [Abstract][Full Text] [Related]
7. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
Linari G; Fleeman L; Gilor C; Giacomelli L; Fracassi F
J Feline Med Surg; 2022 Feb; 24(2):168-176. PubMed ID: 34009061
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.
van Bokhorst KL; Galac S; Kooistra HS; Valtolina C; Fracassi F; Rosenberg D; Meij BP
J Vet Intern Med; 2021 Mar; 35(2):834-842. PubMed ID: 33621385
[TBL] [Abstract][Full Text] [Related]
9. Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism.
Keyte SV; Kenny PJ; Forcada Y; Church DB; Niessen SJ
J Vet Intern Med; 2016 Jul; 30(4):973-82. PubMed ID: 27425382
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.
Fenn J; Kenny PJ; Scudder CJ; Hazuchova K; Gostelow R; Fowkes RC; Forcada Y; Church DB; Niessen SJM
J Vet Intern Med; 2021 Mar; 35(2):823-833. PubMed ID: 33624865
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus.
Alt N; Kley S; Tschuor F; Zapf J; Reusch CE
Res Vet Sci; 2007 Dec; 83(3):331-5. PubMed ID: 17367830
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hypersomatotropism and hyperthyroidism in cats with diabetes mellitus from referral centers in Buenos Aires (2020-2022).
Miceli DD; García JD; Rey Amunategui JP; Pompili GA; Rial LA; Más J; Molina EM; Pignataro OP
J Feline Med Surg; 2023 Feb; 25(2):1098612X221148565. PubMed ID: 36779783
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone excess and the effect of octreotide in cats with diabetes mellitus.
Slingerland LI; Voorhout G; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2008 Nov; 35(4):352-61. PubMed ID: 18801640
[TBL] [Abstract][Full Text] [Related]
14. Effect of insulin treatment on circulating insulin-like growth factor I and IGF-binding proteins in cats with diabetes mellitus.
Strage EM; Sundberg M; Holst BS; Andersson Franko M; Ramström M; Fall T; Lewitt M
J Vet Intern Med; 2018 Sep; 32(5):1579-1590. PubMed ID: 30112786
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and diagnostic potential of serum ghrelin in feline hypersomatotropism and diabetes mellitus.
Jensen KB; Forcada Y; Church DB; Niessen SJ
J Vet Intern Med; 2015 Jan; 29(1):14-20. PubMed ID: 25619512
[TBL] [Abstract][Full Text] [Related]
16. Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.
Niessen SJ; Forcada Y; Mantis P; Lamb CR; Harrington N; Fowkes R; Korbonits M; Smith K; Church DB
PLoS One; 2015; 10(5):e0127794. PubMed ID: 26023776
[TBL] [Abstract][Full Text] [Related]
17. Updates in Feline Diabetes Mellitus and Hypersomatotropism.
Fleeman L; Gostelow R
Vet Clin North Am Small Anim Pract; 2020 Sep; 50(5):1085-1105. PubMed ID: 32680669
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly.
Berg RI; Nelson RW; Feldman EC; Kass PH; Pollard R; Refsal KR
J Vet Intern Med; 2007; 21(5):892-8. PubMed ID: 17939540
[TBL] [Abstract][Full Text] [Related]
19. Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with overweight/obesity.
Miceli DD; Jaliquias A; Gallelli MF; García JD; Vecino C; Rey Amunategui JP; Pompili GA; Espiñeira IM; Más J; Pignataro OP
Domest Anim Endocrinol; 2024 May; 89():106858. PubMed ID: 38830275
[TBL] [Abstract][Full Text] [Related]
20. Feline Comorbidities: Hypersomatotropism-induced diabetes in cats.
Scudder C; Church D
J Feline Med Surg; 2024 Feb; 26(2):1098612X241226690. PubMed ID: 38323402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
